Quick Links

 Selected Publications


Abdou AM, Gao X, Cozen W, ... Wang SS. Human Leukocyte Antigen (HLA) Class I and II, Tumor Necrosis Factor (TNF) G-308A, and Risk of Non-Hodgkin Lymphoma. Leukemia. 2010 (E-pub, Feb 11).

Skibola CF, Bracci PM, Nieters N, ... Wang SS.  Polymorphisms in TNF and LTA are associated with increased risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol 2010;171(3):267-76.

Wang SS, Purdue M, Cerhan JR, et al.  Common genetic variations in the tumor necrosis factor (TNF) and TNF receptor superfamilies and nuclear factor kappa beta transcription factors and risk of non-Hodgkin lymphoma.  Plos One 2009;4(4):e5360.

Lan Q, Morton LM, Armstrong B, ... Wang SS. Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies. Blood 2009;114:264-7.

Colt JS, Rothman N, Severson RK, ... Wang SS. Exposure to organochlorines, genetic variation in immune function genes, and risk of non-Hodgkin lymphoma. Blood 2009; 113(9):1899-905.  

Wang SS, Maurer MJ, Morton LM, et al. Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma. Leukemia 2009; 23(3):596-602.

Morton LM, Wang SS, Cozen W, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 2008; 112(13):5150-60.

Habermann TM, Wang S, Maurer MJ, et al. Host immune gene polymorphisms in combination with clinical and demographic factors predict survival in diffuse large B-cell lymphoma. Blood 2008;112(7):2694-702.

Wang SS, Davis S, Hartge P, et al. Chromosomal aberrations in peripheral blood lymphocytes and risk for non-Hodgkin lymphoma. J Natl Cancer Inst 2008;39:78-82.

Wang SS, Cozen W, Cerhan J, et al. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res 2007;67:5042-54.

Wang SS, Slager S, Brennan P, et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10,211 cases and 11,905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007;109:3479-88.

Cerhan JR, Wang S, Maurer MJ, et al. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood 2007;109:5439-46.

Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006;107:265-76.

Rothman N, Skibola CF, Wang SS, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 2006;7:27-38.

Wang SS, Cerhan JR, Hartge P, et al. Common genetic variants in pro-inflammatory and other immunoregulatory genes and the risk for non-Hodgkin lymphoma. Cancer Res 2006;66:9771-80.

This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 02/10.

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.